Prevalence of Dyschromatopsia in Glaucoma Patients
1 other identifier
observational
N/A
1 country
1
Brief Summary
Glaucoma is a progressive disease resulting in loss of retinal nerve cells and their axons (retinal nerve fibers). Retinal nerve fibers are ordered in a special manner when they enter the optic nerve. Hence, damage to the retinal nerve fibers by glaucoma results in visual field defects at certain locations. Furthermore, the retinal nerve fiber layers from different receptors for different colors are ordered in a special manner as well. Thus, it is possible that glaucomatous damage causes color vision dysfunction (dyschromatopsia). At the moment there is disagreement whether dyschromatopsia occurs at early- to mid-stage or only in end-stage glaucoma. By testing color vision in glaucoma patients the prevalence of dyschromatopsia in glaucoma and in different stages of the disease will be investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 19, 2013
CompletedFirst Posted
Study publicly available on registry
November 26, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedNovember 26, 2013
July 1, 2012
1.1 years
November 19, 2013
November 19, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Result from Ishihara Test
Color vision will be tested once by Ishihara plates. Both eyes will be tested separately.
Visit 1
Secondary Outcomes (1)
Glaucoma stage
Visit 1
Eligibility Criteria
Patients with a diagnosis of open-angle glaucoma of the Glaucoma Department at Massachusetts Eye \& Ear Infirmary, Boston, MA 02114, US
You may qualify if:
- diagnosis of open angle glaucoma
- visual acuity \>/= 20/50
- age \>/= 18 (no upper limit)
- male or female gender
You may not qualify if:
- other type of glaucoma
- age \<18
- other retinal disease (e.g. age related macular degeneration)
- other disease affecting the optic nerve or the retinal nerve fibers
- known color blindness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts Eye & Ear Infirmary
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Douglas J. Rhee, M.D.
Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, MA, US
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2013
First Posted
November 26, 2013
Study Start
November 1, 2012
Primary Completion
December 1, 2013
Study Completion
January 1, 2014
Last Updated
November 26, 2013
Record last verified: 2012-07